KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Operating Margin: 2016-2024

Historic Operating Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to 8.92%.

  • Amneal Pharmaceuticals' Operating Margin fell 368.00% to 8.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.19%, marking a year-over-year increase of 519.00%. This contributed to the annual value of 8.92% for FY2024, which is 39.00% up from last year.
  • As of FY2024, Amneal Pharmaceuticals' Operating Margin stood at 8.92%, which was up 4.51% from 8.54% recorded in FY2023.
  • Amneal Pharmaceuticals' Operating Margin's 5-year high stood at 8.92% during FY2024, with a 5-year trough of -4.29% in FY2022.
  • In the last 3 years, Amneal Pharmaceuticals' Operating Margin had a median value of 8.54% in 2023 and averaged 4.39%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 1,987bps in 2020, then plummeted by 1,159bps in 2022.
  • Over the past 5 years, Amneal Pharmaceuticals' Operating Margin (Yearly) stood at 4.57% in 2020, then spiked by 272bps to 7.29% in 2021, then slumped by 1,159bps to -4.29% in 2022, then soared by 1,283bps to 8.54% in 2023, then surged by 39bps to 8.92% in 2024.